An Alternative Thinking in Tumor Therapeutics: Living Yeast Armored with Silicate.
cancer therapy
immune response
living yeast
silicate
targeting
Journal
ACS nano
ISSN: 1936-086X
Titre abrégé: ACS Nano
Pays: United States
ID NLM: 101313589
Informations de publication
Date de publication:
22 08 2023
22 08 2023
Historique:
medline:
23
8
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
ppublish
Résumé
A hybrid platform, constructed via the surface "armoring" of living yeasts by a manganese silicate compound (MS@Yeast), is investigated for combinational cancer treatment. The intrinsic characteristics of living yeasts, in both acidophilic and anaerobic conditions, empower the hybrid platform with activated selected colonization in tumors. While silicate particles are delivered in a targeting manner, yeast fermentation occurs at the cancerous region, inducing both alcohol and CO
Identifiants
pubmed: 37523324
doi: 10.1021/acsnano.3c06311
doi:
Substances chimiques
Carbon Dioxide
142M471B3J
Silicates
0
Manganese
42Z2K6ZL8P
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM